- Home
- LVS vs BNTX Comparison
LVS vs BNTX Comparison
Compare LVS & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LVS | BNTX |
|---|---|---|
| Founded | 1988 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.4B | 22.9B |
| IPO Year | 2004 | 2019 |
Fundamental Metrics
Financial Performance| Metric | LVS | BNTX |
|---|---|---|
| Price | $35.39 | $88.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 21 |
| Target Price | $57.04 | ★ $116.75 |
| AVG Volume (30 Days) | ★ 5.3M | 1.0M |
| Earning Date | 10-21-2026 | 11-03-2026 |
| Dividend Yield | ★ 3.29% | N/A |
| EPS Growth | ★ 19.90 | N/A |
| EPS | ★ 1.38 | N/A |
| Revenue | ★ $13,017,000,000.00 | N/A |
| Revenue This Year | $5.69 | N/A |
| Revenue Next Year | $5.26 | $0.50 |
| P/E Ratio | $26.46 | ★ N/A |
| Revenue Growth | ★ 15.22 | N/A |
| 52 Week Low | $35.03 | $79.81 |
| 52 Week High | $70.45 | $124.00 |
Technical Indicators
Market Signals| Indicator | LVS | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 29.87 | 38.53 |
| Support Level | $35.28 | $87.98 |
| Resistance Level | $38.59 | $94.18 |
| Average True Range (ATR) | 0.92 | 3.04 |
| MACD | 0.19 | -0.29 |
| Stochastic Oscillator | 10.13 | 6.64 |
Price Performance
Historical ComparisonAbout LVS Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, Sands generates all its EBITDA from Asia, with its casino operations generating the majority of sales.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.